Varex Q3 FY2024 revenue down 10% YoY; Q4 guidance weak

Varex Imaging Corp

2024-Q3 EPS reported $0.06 revenue$605,300,000

Revenue $209M (-10% YoY); GAAP EPS $0.03, Non-GAAP EPS $0.14 vs $0.37 YoY.
Medical segment revenue $149M (-15% YoY); Industrial segment $60M (+6% YoY).
Cash flow from operations $8M; cash and equivalents $192M (flat vs FY2023).
Q4 FY2024 guidance: revenue $190-210M, Non-GAAP EPS $0.00-$0.15, citing challenging market conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.